跳至主要内容
临床试验/CTRI/2023/06/053822
CTRI/2023/06/053822尚未招募4 期

A Comparative study to Evaluate the Efficacy and Safety of Imeglimin with Metformin versus Metformin in Type 2 Diabetes Mellitus patients in a tertiary care hospital,Chengalpattu-A Randomised Controlled Trial

Dr Shaki Sam0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Male & Female population
  • 2)HbA1c >6.5 and <10
  • 3)Patients willing to participate and given written informed consent

排除标准

  • 1)Those who are on insulin therapy or any injectable glucose lowering drugs in the past 30 days.
  • 2)Pregnant and lactating mother
  • 3)Patients with impaired hepatic or renal function
  • 4)Patients with hypertension,congestive cardiac failure,ischemic heart disease.
  • 5)Clinically significant micro vascular and macro vascular complications
  • 6)Patients who didnâ??t give written informed consent.

研究者

发起方
Dr Shaki Sam

相似试验